Interestingly, recent studies have shown that VCP inhibition can improve the effectiveness of cancer immunotherapy by modulating immune responses.27,28 However, the precise mechanisms underlying these effects in the context of HCC remain poorly understood, representing a significant knowledge gap. Here, VCP is linked to hepatocellular carcinoma.